TreeWAS – Variant ID: rs77990856

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
F32.9 Depressive episode, unspecified	0.000	0.994	0.006
M79.66 Pain in limb (Lower leg)	0.000	0.994	0.006
K76.6 Portal hypertension	0.000	0.994	0.006
M79.6 Pain in limb	0.000	0.994	0.006
M79.65 Pain in limb (Pelvic region and thigh)	0.000	0.994	0.006
M79.69 Pain in limb (Site unspecified)	0.000	0.994	0.006
K76.8 Other specified diseases of liver	0.000	0.994	0.006
M79.64 Pain in limb (Hand)	0.000	0.995	0.005
K76 Other diseases of liver	0.000	0.995	0.005
M79.63 Pain in limb (Forearm)	0.000	0.995	0.005
M79.62 Pain in limb (Upper arm)	0.000	0.995	0.005
M79.60 Pain in limb (Multiple sites)	0.000	0.995	0.005
M65.34 Trigger finger-Hand	0.000	0.995	0.005
M79.68 Pain in limb (Other)	0.000	0.995	0.005
M79.61 Pain in limb (Shoulder region)	0.000	0.996	0.004
K76.9 Liver disease, unspecified	0.000	0.996	0.004
G81.9 Hemiplegia, unspecified	0.000	0.996	0.004
K76.0 Fatty (change of) liver, not elsewhere classified	0.000	0.996	0.004
K76.5 Hepatic veno-occlusive disease	0.000	0.996	0.004
K76.4 Peliosis hepatis	0.000	0.996	0.004
K76.3 Infarction of liver	0.000	0.996	0.004
K76.2 Central haemorrhagic necrosis of liver	0.000	0.996	0.004
K76.1 Chronic passive congestion of liver	0.000	0.996	0.004
Z03.4 Observation for suspected myocardial infarction	0.000	0.996	0.004
M79.67 Pain in limb (Ankle and foot)	0.000	0.996	0.004
I47.2 Ventricular tachycardia	0.000	0.996	0.004
Z03.5 Observation for other suspected cardiovascular diseases	0.000	0.996	0.004
Y43.3 Other antineoplastic drugs	0.004	0.996	0.000
K76.7 Hepatorenal syndrome	0.000	0.996	0.004
O70.0 First degree perineal laceration during delivery	0.000	0.996	0.004
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.004	0.996	0.000
Y43 Primarily systemic agents	0.004	0.996	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
Y57.8 Other drugs and medicaments	0.003	0.997	0.000
N88.8 Other specified noninflammatory disorders of cervix uteri	0.003	0.997	0.000
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.003	0.997	0.000
Z03 Medical observation and evaluation for suspected diseases and conditions	0.000	0.997	0.003
Y43.4 Immunosuppressive agents	0.003	0.997	0.000
Z13.9 Special screening examination, unspecified	0.000	0.997	0.003
J18.1 Lobar pneumonia, unspecified	0.000	0.997	0.003
Z03.9 Observation for suspected disease or condition, unspecified	0.000	0.997	0.003
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
D18.0 Haemangioma, any site	0.003	0.997	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.003	0.997	0.000
Y43.9 Primarily systemic agent, unspecified	0.003	0.997	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.003	0.997	0.000
Y43.6 Enzymes, not elsewhere classified	0.003	0.997	0.000
Y43.5 Acidifying and alkalising agents	0.003	0.997	0.000
Y43.2 Antineoplastic natural products	0.003	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.003	0.997	0.000
Y43.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
Y57.5 X-ray contrast media	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
M47.96 Spondylosis, unspecified (Lumbar region)	0.000	0.997	0.003
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
M65.3 Trigger finger	0.000	0.997	0.003
Y45.1 Salicylates	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
Y42.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
Y42.4 Oral contraceptives	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
Z03.3 Observation for suspected nervous system disorder	0.000	0.997	0.003
H20.9 Iridocyclitis, unspecified	0.003	0.997	0.000
I49.3 Ventricular premature depolarisation	0.000	0.997	0.003
M47.99 Spondylosis, unspecified (Site unspecified)	0.000	0.997	0.003
Y42.5 Other oestrogens and progestogens	0.002	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.997	0.000
Y40.8 Other systemic antibiotics	0.002	0.997	0.000
Y45.2 Propionic acid derivatives	0.002	0.997	0.000
Z03.2 Observation for suspected mental and behavioural disorders	0.000	0.997	0.002
Z03.0 Observation for suspected tuberculosis	0.000	0.997	0.002
I47 Paroxysmal tachycardia	0.000	0.998	0.002
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
L40.5 Arthropathic psoriasis	0.000	0.998	0.002
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
S82.80 Fractures of other parts of lower leg (closed)	0.000	0.998	0.002
I47.1 Supraventricular tachycardia	0.000	0.998	0.002
G81 Hemiplegia	0.000	0.998	0.002
K82.4 Cholesterolosis of gallbladder	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
Z03.6 Observation for suspected toxic effect from ingested substance	0.000	0.998	0.002
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
O70 Perineal laceration during delivery	0.000	0.998	0.002
M65.39 Trigger finger-Site unspec	0.000	0.998	0.002
M65.38 Trigger finger-Other	0.000	0.998	0.002
M65.37 Trigger finger-Ankle/foot	0.000	0.998	0.002
M65.36 Trigger finger-Lower leg	0.000	0.998	0.002
M65.35 Trigger finger-Pelvic/thigh	0.000	0.998	0.002
M65.33 Trigger finger-Forearm	0.000	0.998	0.002
M65.32 Trigger finger-Upper arm	0.000	0.998	0.002
M65.31 Trigger finger-Shldr region	0.000	0.998	0.002
M65.30 Trigger finger-Mult sites	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
M47.9 Spondylosis, unspecified	0.000	0.998	0.002
Y40.0 Penicillins	0.002	0.998	0.000
O70.2 Third degree perineal laceration during delivery	0.000	0.998	0.002
Z30.2 Sterilisation	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
M47.92 Spondylosis, unspecified (Cervical region)	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
I73.9 Peripheral vascular disease, unspecified	0.000	0.998	0.002
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
H20 Iridocyclitis	0.002	0.998	0.000
I47.0 Reentry ventricular arrhythmia	0.000	0.998	0.002
F43.2 Adjustment disorders	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
G81.1 Spastic hemiplegia	0.000	0.998	0.002
G81.0 Flaccid hemiplegia	0.000	0.998	0.002
L03.3 Cellulitis of trunk	0.000	0.998	0.002
Y44.2 Anticoagulants	0.002	0.998	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.002	0.998	0.000
I47.9 Paroxysmal tachycardia, unspecified	0.000	0.998	0.002
O70.3 Fourth degree perineal laceration during delivery	0.000	0.998	0.002
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M47.95 Spondylosis, unspecified (Thoracolumbar region)	0.000	0.998	0.002
M47.94 Spondylosis, unspecified (Thoracic region)	0.000	0.998	0.002
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.000	0.998	0.002
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.000	0.998	0.002
H21.0 Hyphaema	0.002	0.998	0.000
O70.9 Perineal laceration during delivery, unspecified	0.000	0.998	0.002
H20.0 Acute and subacute iridocyclitis	0.002	0.998	0.000
Z95.4 Presence of other heart-valve replacement	0.002	0.998	0.000
H21 Other disorders of iris and ciliary body	0.002	0.998	0.000
M23.8 Other internal derangements of knee	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
Q21.1 Atrial septal defect	0.002	0.998	0.000
H20.8 Other iridocyclitis	0.002	0.998	0.000
H20.2 Lens-induced iridocyclitis	0.002	0.998	0.000
H20.1 Chronic iridocyclitis	0.002	0.998	0.000
Q23.1 Congenital insufficiency of aortic valve	0.002	0.998	0.000
I49.4 Other and unspecified premature depolarisation	0.000	0.998	0.002
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.000	0.998	0.002
I78.1 Naevus, nonneoplastic	0.000	0.998	0.002
Q21 Congenital malformations of cardiac septa	0.002	0.998	0.000
G91.9 Hydrocephalus, unspecified	0.002	0.998	0.000
I49 Other cardiac arrhythmias	0.000	0.998	0.002
Q23 Congenital malformations of aortic and mitral valves	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.998	0.000
Z03.8 Observation for other suspected diseases and conditions	0.000	0.998	0.002
H21.9 Disorder of iris and ciliary body, unspecified	0.001	0.998	0.000
H21.8 Other specified disorders of iris and ciliary body	0.001	0.998	0.000
H21.4 Pupillary membranes	0.001	0.998	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.001	0.998	0.000
H21.2 Degeneration of iris and ciliary body	0.001	0.998	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.001	0.998	0.000
O70.1 Second degree perineal laceration during delivery	0.000	0.998	0.002
L40 Psoriasis	0.000	0.998	0.002
M23.87 Other internal derangements of knee (Capsular ligament)	0.001	0.998	0.000
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)	0.001	0.998	0.000
M23.85 Other internal derangements of knee (Posterior horn of lateral meniscus)	0.001	0.998	0.000
M23.84 Other internal derangements of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.001	0.998	0.000
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.001	0.998	0.000
M23.82 Other internal derangements of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.001	0.998	0.000
M23.80 Other internal derangements of knee (Multiple sites)	0.001	0.998	0.000
K81.9 Cholecystitis, unspecified	0.002	0.998	0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.000	0.998	0.001
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.998	0.002
D18 Haemangioma and lymphangioma, any site	0.001	0.998	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.001	0.998	0.000
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.998	0.001
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.001	0.998	0.000
O04.9 Complete or unspecified, without complication	0.001	0.998	0.000
Q21.0 Ventricular septal defect	0.001	0.998	0.000
V44.5 Driver injured in traffic accident	0.001	0.998	0.000
Z03.1 Observation for suspected malignant neoplasm	0.000	0.998	0.001
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.001	0.998	0.000
N88 Other noninflammatory disorders of cervix uteri	0.001	0.998	0.000
Q21.9 Congenital malformation of cardiac septum, unspecified	0.001	0.999	0.000
Q21.8 Other congenital malformations of cardiac septa	0.001	0.999	0.000
Q21.4 Aortopulmonary septal defect	0.001	0.999	0.000
Q21.3 Tetralogy of Fallot	0.001	0.999	0.000
Q21.2 Atrioventricular septal defect	0.001	0.999	0.000
M13.91 Arthritis, unspecified (Shoulder region)	0.000	0.999	0.001
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)	0.001	0.999	0.000
I49.2 Junctional premature depolarisation	0.000	0.999	0.001
L40.0 Psoriasis vulgaris	0.000	0.999	0.001
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.001	0.999	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.001	0.999	0.000
Q23.4 Hypoplastic left heart syndrome	0.001	0.999	0.000
Q23.3 Congenital mitral insufficiency	0.001	0.999	0.000
Q23.2 Congenital mitral stenosis	0.001	0.999	0.000
Q23.0 Congenital stenosis of aortic valve	0.001	0.999	0.000
F32 Depressive episode	0.000	0.999	0.001
K70-K77 Diseases of liver	0.000	0.999	0.001
F43.1 Posttraumatic stress disorder	0.001	0.999	0.000
H18.8 Other specified disorders of cornea	0.001	0.999	0.000
I49.5 Sick sinus syndrome	0.000	0.999	0.001
I49.1 Atrial premature depolarisation	0.000	0.999	0.001
L40.9 Psoriasis, unspecified	0.000	0.999	0.001
Z13 Special screening examination for other diseases and disorders	0.000	0.999	0.001
I49.9 Cardiac arrhythmia, unspecified	0.000	0.999	0.001
L40.8 Other psoriasis	0.000	0.999	0.001
L40.4 Guttate psoriasis	0.000	0.999	0.001
L40.3 Pustulosis palmaris et plantaris	0.000	0.999	0.001
L40.2 Acrodermatitis continua	0.000	0.999	0.001
L40.1 Generalised pustular psoriasis	0.000	0.999	0.001
Y87.1 Sequelae of assault	0.001	0.999	0.000
M13.96 Arthritis, unspecified (Lower leg)	0.000	0.999	0.001
I42.0 Dilated cardiomyopathy	0.000	0.999	0.001
V44 Car occupant injured in collision with heavy transport vehicle or bus	0.001	0.999	0.000
E87.1 Hypo-osmolality and hyponatraemia	0.000	0.999	0.001
H17 Corneal scars and opacities	0.001	0.999	0.000
K74 Fibrosis and cirrhosis of liver	0.000	0.999	0.001
M84.03 Malunion of fracture (Forearm)	0.001	0.999	0.000
D18.1 Lymphangioma, any site	0.001	0.999	0.000
M75.0 Adhesive capsulitis of shoulder	0.000	0.999	0.001
Z04.9 Examination and observation for unspecified reason	0.000	0.999	0.001
F43 Reaction to severe stress, and adjustment disorders	0.001	0.999	0.000
H18 Other disorders of cornea	0.001	0.999	0.000
Q28 Other congenital malformations of circulatory system	0.001	0.999	0.000
Q27 Other congenital malformations of peripheral vascular system	0.001	0.999	0.000
Q26 Congenital malformations of great veins	0.001	0.999	0.000
Q25 Congenital malformations of great arteries	0.001	0.999	0.000
Q24 Other congenital malformations of heart	0.001	0.999	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.001	0.999	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.001	0.999	0.000
I42.2 Other hypertrophic cardiomyopathy	0.000	0.999	0.001
I73.0 Raynaud's syndrome	0.000	0.999	0.001
K74.6 Other and unspecified cirrhosis of liver	0.000	0.999	0.001
L03.9 Cellulitis, unspecified	0.000	0.999	0.001
N88.4 Hypertrophic elongation of cervix uteri	0.001	0.999	0.000
N88.3 Incompetence of cervix uteri	0.001	0.999	0.000
N88.1 Old laceration of cervix uteri	0.001	0.999	0.000
N88.0 Leukoplakia of cervix uteri	0.001	0.999	0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.001	0.999	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.001	0.999	0.000
H15 Disorders of sclera	0.001	0.999	0.000
H61.0 Perichondritis of external ear	0.001	0.999	0.000
I42.9 Cardiomyopathy, unspecified	0.000	0.999	0.001
I73 Other peripheral vascular diseases	0.000	0.999	0.001
Q82.5 Congenital nonneoplastic naevus	0.001	0.999	0.000
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.001	0.999	0.000
F32.8 Other depressive episodes	0.000	0.999	0.001
Q50.4 Embryonic cyst of Fallopian tube	0.001	0.999	0.000
Z13.8 Special screening examination for other specified diseases and disorders	0.000	0.999	0.001
Z13.7 Special screening examination for congenital malformations, deformations and chromosomal abnormalities	0.000	0.999	0.001
Z13.4 Special screening examination for certain developmental disorders in childhood	0.000	0.999	0.001
Z13.2 Special screening examination for nutritional disorders	0.000	0.999	0.001
K77 Liver disorders in diseases classified elsewhere	0.000	0.999	0.001
K73 Chronic hepatitis, not elsewhere classified	0.000	0.999	0.001
K71 Toxic liver disease	0.000	0.999	0.001
L03 Cellulitis	0.000	0.999	0.001
V40-V49 Car occupant injured in transport accident	0.001	0.999	0.000
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.001	0.999	0.000
E89.0 Postprocedural hypothyroidism	0.000	0.999	0.001
H17.9 Corneal scar and opacity, unspecified	0.001	0.999	0.000
I49.8 Other specified cardiac arrhythmias	0.000	0.999	0.001
I60.9 Subarachnoid haemorrhage, unspecified	0.001	0.999	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.001	0.999	0.000
V48 Car occupant injured in noncollision transport accident	0.001	0.999	0.000
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.001	0.999	0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)	0.001	0.999	0.000
H18.9 Disorder of cornea, unspecified	0.001	0.999	0.000
H44.2 Degenerative myopia	0.001	0.999	0.000
V44.6 Passenger injured in traffic accident	0.001	0.999	0.000
V44.9 Unspecified car occupant injured in traffic accident	0.001	0.999	0.000
V44.7 Person on outside of vehicle injured in traffic accident	0.001	0.999	0.000
V44.4 Person injured while boarding or alighting	0.001	0.999	0.000
V44.3 Unspecified car occupant injured in nontraffic accident	0.001	0.999	0.000
V44.2 Person on outside of vehicle injured in nontraffic accident	0.001	0.999	0.000
V44.1 Passenger injured in nontraffic accident	0.001	0.999	0.000
V44.0 Driver injured in nontraffic accident	0.001	0.999	0.000
V48.4 Person injured while boarding or alighting	0.001	0.999	0.000
V49.9 Car occupant [any] injured in unspecified traffic accident	0.001	0.999	0.000
I42 Cardiomyopathy	0.000	0.999	0.001
F32.0 Mild depressive episode	0.000	0.999	0.001
F43.9 Reaction to severe stress, unspecified	0.001	0.999	0.000
F43.8 Other reactions to severe stress	0.001	0.999	0.000
F43.0 Acute stress reaction	0.001	0.999	0.000
H17.8 Other corneal scars and opacities	0.001	0.999	0.000
H17.1 Other central corneal opacity	0.001	0.999	0.000
H17.0 Adherent leukoma	0.001	0.999	0.000
H18.7 Other corneal deformities	0.001	0.999	0.000
H18.6 Keratoconus	0.001	0.999	0.000
H18.3 Changes in corneal membranes	0.001	0.999	0.000
H18.2 Other corneal oedema	0.001	0.999	0.000
H18.1 Bullous keratopathy	0.001	0.999	0.000
H18.0 Corneal pigmentations and deposits	0.001	0.999	0.000
K74.5 Biliary cirrhosis, unspecified	0.000	0.999	0.001
K74.4 Secondary biliary cirrhosis	0.000	0.999	0.001
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.999	0.001
K74.1 Hepatic sclerosis	0.000	0.999	0.001
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.001	0.999	0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.001	0.999	0.000
Q20.6 Isomerism of atrial appendages	0.001	0.999	0.000
Q20.5 Discordant atrioventricular connexion	0.001	0.999	0.000
Q20.4 Double inlet ventricle	0.001	0.999	0.000
Q20.3 Discordant ventriculoarterial connexion	0.001	0.999	0.000
Q20.2 Double outlet left ventricle	0.001	0.999	0.000
Q20.1 Double outlet right ventricle	0.001	0.999	0.000
Q20.0 Common arterial trunk	0.001	0.999	0.000
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.001	0.999	0.000
Q22.8 Other congenital malformations of tricuspid valve	0.001	0.999	0.000
Q22.6 Hypoplastic right heart syndrome	0.001	0.999	0.000
Q22.5 Ebstein's anomaly	0.001	0.999	0.000
Q22.4 Congenital tricuspid stenosis	0.001	0.999	0.000
Q22.3 Other congenital malformations of pulmonary valve	0.001	0.999	0.000
Q22.2 Congenital pulmonary valve insufficiency	0.001	0.999	0.000
Q22.1 Congenital pulmonary valve stenosis	0.001	0.999	0.000
Q22.0 Pulmonary valve atresia	0.001	0.999	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.001	0.999	0.000
Q24.8 Other specified congenital malformations of heart	0.001	0.999	0.000
Q24.6 Congenital heart block	0.001	0.999	0.000
Q24.5 Malformation of coronary vessels	0.001	0.999	0.000
Q24.4 Congenital subaortic stenosis	0.001	0.999	0.000
Q24.3 Pulmonary infundibular stenosis	0.001	0.999	0.000
Q24.2 Cor triatriatum	0.001	0.999	0.000
Q24.1 Levocardia	0.001	0.999	0.000
Q24.0 Dextrocardia	0.001	0.999	0.000
Q25.9 Congenital malformation of great arteries, unspecified	0.001	0.999	0.000
Q25.8 Other congenital malformations of great arteries	0.001	0.999	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.001	0.999	0.000
Q25.6 Stenosis of pulmonary artery	0.001	0.999	0.000
Q25.5 Atresia of pulmonary artery	0.001	0.999	0.000
Q25.4 Other congenital malformations of aorta	0.001	0.999	0.000
Q25.3 Stenosis of aorta	0.001	0.999	0.000
Q25.2 Atresia of aorta	0.001	0.999	0.000
Q25.1 Coarctation of aorta	0.001	0.999	0.000
Q25.0 Patent ductus arteriosus	0.001	0.999	0.000
Q26.9 Congenital malformation of great vein, unspecified	0.001	0.999	0.000
Q26.8 Other congenital malformations of great veins	0.001	0.999	0.000
Q26.6 Portal vein-hepatic artery fistula	0.001	0.999	0.000
Q26.5 Anomalous portal venous connexion	0.001	0.999	0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.001	0.999	0.000
Q26.3 Partial anomalous pulmonary venous connexion	0.001	0.999	0.000
Q26.2 Total anomalous pulmonary venous connexion	0.001	0.999	0.000
Q26.1 Persistent left superior vena cava	0.001	0.999	0.000
Q26.0 Congenital stenosis of vena cava	0.001	0.999	0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.001	0.999	0.000
Q27.8 Other specified congenital malformations of peripheral vascular system	0.001	0.999	0.000
Q27.4 Congenital phlebectasia	0.001	0.999	0.000
Q27.3 Peripheral arteriovenous malformation	0.001	0.999	0.000
Q27.2 Other congenital malformations of renal artery	0.001	0.999	0.000
Q27.1 Congenital renal artery stenosis	0.001	0.999	0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.001	0.999	0.000
Q28.9 Congenital malformation of circulatory system, unspecified	0.001	0.999	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.001	0.999	0.000
Q28.3 Other malformations of cerebral vessels	0.001	0.999	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.001	0.999	0.000
Q28.1 Other malformations of precerebral vessels	0.001	0.999	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.001	0.999	0.000
Z13.1 Special screening examination for diabetes mellitus	0.000	0.999	0.001
H16 Keratitis	0.001	0.999	0.000
M79 Other soft tissue disorders, not elsewhere classified	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations